URSAPHARM Arzneimittel y CEBINA anuncian una colaboración para readaptar el antihistamínico azelastine para combatir la COVID-19 This campaign accomplished one hundred% of its event PR goals and secured the very best quantity of coverage to this point to the TechConnection event. We also use third-get together cookies that help us analyze